February 2025 – Talk Bio

Eli Lilly Partners with Magnet Biomedicine in $1.25B Molecular Glue Deal

2 months ago talkbio0Tagged Biomedicine, Collaboration, Drug Discovery, Eli, Eli Lilly, Magnet, molecular glue, Neoplasms

Eli Lilly, Magnet Biomedicine, molecular glue, drug discovery, oncology, collaboration

Merck & Co. predicts Keytruda will undergo IRA price cuts before patent cliff

2 months ago talkbio0Tagged Impact food supplement, IRA, Keytruda, Merck, Patent Cliff, Prices, Sales - occupational activity, U.S.

Merck, Keytruda, Prices, IRA, Sales – occupational activity, patent cliff, Impact food supplement, U.S., Keytruda

Eikon pulls in $351M as lead drug begins Phase III journey

2 months ago talkbio0

Eikon Therapeutics Secures $351M Funding for Cancer Drug Development Eikon Therapeutics raised $351 million in a Series D funding round124 Total funding raised since 2019 launch now exceeds $1.1 billion1 Lead drug EIK1001 has entered Phase III trials for advanced melanoma14 Clinical studies ongoing in 28 countries across 5 continents14 ## Pipeline Highlights: EIK1001: TLR7/8 […]

Eikon pulls in $351M as lead drugs begins Phase III journey

2 months ago talkbio0

Eikon Therapeutics Secures $350.7 Million Series D to Advance Cancer Drug Pipeline Eikon Therapeutics, a pivotal-stage biotechnology company, has raised $350.7 million in a Series D financing round to support its clinical-stage programs and future pipeline development147. This significant funding brings Eikon’s total capital raised since its founding in 2019 to over $1.1 billion17. ## […]

Eli Lilly Acquires Organovo’s FXR Program for $10M, Triggering 244% Stock Surge

2 months ago talkbio0Tagged Acquisition, Eli, Eli Lilly, FXR314, Increase, Inflammatory Bowel Diseases, NR1H4 gene, Organovo, Prices, Programs - Publication Format

Eli Lilly, Organovo, FXR program, FXR314, acquisition, inflammatory bowel disease (IBD), stock price increase

Grey’s Anatomy Star Kate Walsh Partners with GRAIL for Multi-Cancer Early Detection Awareness Campaign

2 months ago talkbio0Tagged Grail, Kate Walsh, MCED, multi-cancer early detection, Screening for cancer

Kate Walsh, GRAIL, multi-cancer early detection (MCED), Generation Possible, cancer screening, blood test

FDA updates Boston Scientific’s Accolade pacemaker recall, reporting 832 injuries

2 months ago talkbio0Tagged Artificial cardiac pacemaker, Medical Devices, Mental Recall, Preventive monitoring, trauma qualifier, United States Food and Drug Administration

United States Food and Drug Administration, Mental Recall, Preventive monitoring, trauma qualifier, Medical Devices, Artificial cardiac pacemaker

Beyond the Diagnosis: Embracing the Humanity Behind Epilepsy Care

2 months ago talkbio0Tagged Comprehensive, Empowered, Epilepsy, Experience, Holistic epilepsy management, Interdisciplinary Studies, Patient-Centered, Quality of life

Patient-centered epilepsy care, Holistic epilepsy management, Quality of life in epilepsy, Empowering epilepsy patients, Multidisciplinary epilepsy treatment, Epilepsy patient experiences, Comprehensive epilepsy support